Journey Medical (DERM)
(Delayed Data from NSDQ)
$5.15 USD
-0.14 (-2.65%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $5.16 +0.01 (0.19%) 7:46 PM ET
5-Strong Sell of 5 5
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Journey Medical Corporation [DERM]
Reports for Purchase
Showing records 21 - 40 ( 50 total )
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Model Update - Revenue Growth Still Targeted at 40%+
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
We launch coverage with a Buy rating and $15/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Journey Medical Corporation
Industry: Medical - Drugs
With Proposed Acquisition by Lilly, We Move to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Journey Medical Corporation
Industry: Medical - Drugs
Midcourse Adjustment Though Destination Stays Unchanged; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Journey Medical Corporation
Industry: Medical - Drugs
Lebrikizumab Kicks off Phase 3 and Reinforces Dermira''s Value; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Journey Medical Corporation
Industry: Medical - Drugs
Company: Journey Medical Corporation
Industry: Medical - Drugs
Takeaways From Our Coverage at the Global Investment Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D